Further, we demonstrated that this inhibition was also mediated through suppression of upstream kinase IKK, similar to BMS-345541 (a specific inhibitor of IKK) and, thereby, blocked NF-κB activation in both CRC cells. The gene discussed is NFKB1; the disease is colorectal carcinoma.